Preliminary trial of a digital self-management intervention for epilepsy in Germany

Not Applicable

• Conditions: G40; Epilepsy

• Registration Number: DRKS00030175
• Lead Sponsor: euroventis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-02
• Study Completion: 2023-01-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

Age: 18+ years old
Smartphone Android 5.1+ or iPhone
Ability to use a smartphone
German-speaking
Patient willing to participate (informed consent)
Diagnosis of epilepsy (ICD10 G40)
Active epilepsy: At least 1 seizure in last 6 months

Exclusion Criteria

History of psychosis, suicidal ideation or suicide attempt
Used Helpilepsy or similar app for at least 1 month during past 12 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
EASE (self-Efficacy, Assertiveness, Social support, self-awareness, and hElpful thinking), Baseline + 12 weeks visit 2, patient-reported questionnaire

Secondary Outcome Measures

Name	Time	Method
Epilepsy Knowledge Scale, patient-reported, baseline + visit 2 (12 weeks)<br>Health Literacy Questionnaire (HLQ), patient-reported, baseline + visit 2 (12 weeks)<br>QOLIE-31-P, patient-reported, baseline + visit 2 (12 weeks)<br>HADS, patient-reported, baseline + visit 2 (12 weeks)<br>Seizure frequency, physician-reported, baseline + visit 2 (12 weeks)<br>Seizure severity questionnaire, patient-reported, baseline + visit 2 (12 weeks)